Last week, we provided a 'deep dive' on Jazz Pharmaceuticals (JAZZ). After the research, we passed on making any investment recommendation on the mid-cap biopharma. In part, this was because there was a potentially better candidate in the pipeline of a much smaller biopharma that could be superior if approved compared to Jazz's flagship product. Today, we take an in-depth look at that smaller name.
Company Overview:
Avadel Pharmaceuticals (AVDL) is a Dublin, Ireland-based specialty pharmaceutical company. In 2017, Flamel, Eclat, and FCS Pediatrics became Avadel Pharmaceuticals after completing